Complete TMF Health: Introducing LiveTMF

TransPerfect Life Sciences and Virtual Data Corp are coming together to deliver validated artificial intelligence solutions that support your clinical trial’s overall TMF health. TransPerfect’s Automate and Virtual Data Corp’s LiveTMF™ integrate directly on top of your existing electronic Trial Master File (eTMF) to serve as a continuous compliance layer. These connected AI tools enable clinical operations teams to improve completeness, timeliness, and quality.

Schedule a Demo
TMF filing and indexing

Your EDL Updates in Real Time

Every expected record has a cause, and your TMF Plan and SOPs already define what each one requires. LiveTMF applies those rules the day the event occurs, reconfiguring expected record lists (or "EDLs") using live study data. This closes the gap between what you expect your TMF to contain and what it actually does.

1. Study Changes

A site activates, an amendment takes effect, a case is assessed as a SUSAR, or a record fulfills a placeholder.

2. Rules Apply

LiveTMF applies the rules already defined in the reference model, your TMF plan, other plans, and your policies and SOPs with the protocol as context.

3. EDL Updates

The EDL automatically reflects what is owed, filed, or not yet due. The reason why, with references, is also available, providing regulatory and policy justification.

LiveTMF

Unlock the eTMF Time Machine

Can you explain exactly what your study owes, not just today, but on a specific date?

LiveTMF derives obligations from a study’s events and amendments and checks them against what was filed. The list recalculates and updates itself along with the rationale. You'll always be prepared to answer inspectors’ questions with an EDL that references what the study owed and what your team knew, at any point in the past.

Reduce Inspection Risks with an “Inspection-Steady” eTMF

Up to 90%

less manual EDL management with LiveTMF, giving ClinOps teams weeks back every year and keeping the TMF inspection-ready.


Critical

grade given to a TMF that's too incomplete for inspection, as outlined in the 2026 MHRA GCP Inspection Guidance.

#2

most-cited FDA inspection observation in FY2025: inadequate or inaccurate case history records, 21 CFR 312.62(b).

12%

of critical and major GCP findings in the EMA GCP IWG 2024 report were essential document failures, the largest single category.

  • Icon ai portal
  • Your eTMF

    LiveTMF reads the eTMF without changing anything about how sites and CROs file records or requiring additional software.

  • Icon R&D
  • Your Rules

    Automation is configured according to your TMF and SOPs and managed under your change-control procedures.

  • Icon quality
  • Built for Validation

    Designed to support GAMP 5, 21 CFR Part 11 and Annex 11 requirements, with ALCOA+ audit trails.

    Ready to say goodbye to stale, static EDLs?

    LiveTMF adds a continuous compliance layer that sits directly on top of your eTMF, so you’ll never have to worry about outdated expected record lists again.

    Schedule a demo today to see LiveTMF in action.

    How did you hear about us?
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    eConsent: Why the Content Matters as Much as the Tech

    Insights from a conversation with Edwin Cohen, Principal Consultant / Owner at C&Flow Instrument Creation and Mark P Wade Global Practice Leader & COA SME, TransPerfect Life Sciences For all the attention paid to the systems, platforms, and integrations behind electronic informed consent (eConsent), the real barrier to adoption may not be technical at all. It may be the words on the page. That's the central argument from Edwin Cohen, whose research has ...

    eConsent: Why the Content Matters as Much as the Tech

    LifeSci Talks COA Series | The "Frankenstein Instrument" Problem: Why Some PRO Measures Don't Fit Today's Patients

    Are the COA Instruments we've relied on for decades still measuring what matters to patients today? In this episode, Mark Wade sits down with Kathrin Fischer PhD, Patient-Centered Outcome Strategy Lead at Boehringer Ingelheim and ISOQOL Director-at-Large Term: 2024 – 2027, ...

    Has eCOA Lived up to Its Promise? A Retrospective View on the Evolution of Electronic Clinical Outcome Assessments

    The Evolution of eCOA: Progress, Challenges, and the Road AheadElectronic clinical outcome assessments (eCOAs) were expected to make paper obsolete by improving data quality, reducing missing data, and enabling decentralized clinical trials.More than two decades later, that...

    How a Leading eCOA Provider Cut Timelines by 60% with GlobalLink Strings Integration

    Discover how a leading eCOA provider slashed project timelines by 30% and screenshot review cycles by more than 60% by integrating GlobalLink Strings into its platform. This case study breaks down the roadmap, the rollout, and the efficiency gains that followed. See how ...

    Breaking Down Silos: The Key to Effective Collaboration and Safety Signal Management

    Insights from an XTalks webinar on collaboration between Medical Information, Pharmacovigilance, and Regulatory AffairsIn pharmaceutical organizations, critical safety information is often received by multiple teams. Medical Information (MI) receives inquiries from healthcare...

    The 5-Step AI Readiness Checklist for Medical Device Manufacturers

    Only one in four manufacturers using process AI say it's meeting expectations. The gap between those results and the rest comes down to preparation. This checklist is built from patterns shared by manufacturers that are seeing results, along with the gaps most commonly found ...

    LifeSci Talks COA Series | eConsent: Why the Content Matters as Much as the Tech

    In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Edwin Cohen, Principal Consultant at C&Flow, to talk about eConsent adoption in clinical trials. They discuss the research behind why animated, electronic consent ...